GNRH1 and ovarian hyperstimulation syndrome: In GnRH antagonist (GnRH-ant) protocols, the use of a GnRH agonist (GnRHa) as an alternative to hCG for final oocyte maturation has been proposed to reduce the risk of OHSS.